The Power of 5 Fenbendazole, Ivermectin, Mebendazole, Albendazole and Methylene Blue

The Power of 5 Support Pack brings together five repurposed compounds commonly discussed in integrative oncology research. Each has been investigated for different cellular and metabolic mechanisms, allowing for a broader, multi-pathway approach rather than relying on one compound alone.

Included

• Liposomal Fenbendazole 222 mg × 60
• Mebendazole 200 mg × 45
• Albendazole 200 mg × 30
• Ivermectin 12 mg × 60
• Methylene Blue 10 mg × 60

This pack is intended for people who have already discussed repurposed medicines with an appropriately qualified medical professional and want the products organised in one convenient combination.

Five repurposed tools. Multiple pathways. One comprehensive support pack.

This is a supportive, experimental pack and is not a replacement for oncology treatment or medical care. These compounds are not established cancer treatments, and fenbendazole is not approved as a human medicine.

Individual suitability, prescribed treatment, liver and kidney function, blood counts and possible interactions must be reviewed before use. Combining mebendazole and albendazole may increase the need for liver and blood-count monitoring. Methylene blue can interact dangerously with antidepressants and other serotonergic medicines and may be unsuitable in G6PD deficiency, pregnancy and certain medical conditions.

Off-label medicines require appropriate prescribing where applicable and ongoing professional oversight.